Research Article
The Association of Complements, TGF-β, and IL-6 with Disease Activity, Renal Damage, and Hematological Activity in Patients with Naïve SLE
Table 1
Patient’s characteristics.
| Characteristics (n/mean ± SD/median (95% CI)) |
| Sex (female : male) | 30 : 0 | Age | 31.3 ± 10.5 years | SLAM score | 29.30 ± 3.88 | BUN | 14 (11–19) mg/dL | Creatinine | 0.725 (0.54–1.20) mg/dL | Proteinuria | | Unremarkable (0) | 5 | Moderate (+1 and +2) | 19 | Severe (+3 and +4) | 6 | Leukocyte | 8056 ± 3442 cells/μL | Platelet | 190500 (52000–305000) cells/μL | Hematocrit | 21.96 ± 6.578% | ESR | 61.83 ± 38.18 mm/hour | Hemoglobin | 7.13 ± 2.32 g/dL | Lymphocyte | 967.9 ± 427.8 cells/μL | CRP | 7.84 (3.20–26.21) mg/L | C3 | 28.88 ± 12.98 mg/dL | C4 | 15.25 (7.60–20.60) mg/dL | TGF-β | 35 ± 7.02 ng/mL | IL-6 | 200.6 (127.6–300.5) pg/mL | Anti-dsDNA | 155.32 ± 186.10 IU/mL | ANA test | 86.61 (65.50–184.6) |
|
|
SLAM, systemic lupus activity measurement; BUN, blood urea nitrogen; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; C3, complement 3; C4, complement 4; TGF-β, transforming growth factor-beta; IL, interleukin; dsDNA, double-stranded DNA; ANA, antinuclear antibody.
|